tert-butyl 4-(((2-((4-(3-(2-fluorophenyl)acryloyl)phenyl)amino)-2-oxoethyl)thio)carbonothioyl)piperazine-1-carboxylate

ID: ALA5201233

Chembl Id: CHEMBL5201233

PubChem CID: 168290274

Max Phase: Preclinical

Molecular Formula: C27H30FN3O4S2

Molecular Weight: 543.69

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)OC(=O)N1CCN(C(=S)SCC(=O)Nc2ccc(C(=O)/C=C/c3ccccc3F)cc2)CC1

Standard InChI:  InChI=1S/C27H30FN3O4S2/c1-27(2,3)35-25(34)30-14-16-31(17-15-30)26(36)37-18-24(33)29-21-11-8-20(9-12-21)23(32)13-10-19-6-4-5-7-22(19)28/h4-13H,14-18H2,1-3H3,(H,29,33)/b13-10+

Standard InChI Key:  JLVKZAFEAVEIAS-JLHYYAGUSA-N

Alternative Forms

  1. Parent:

    ALA5201233

    ---

Associated Targets(Human)

HAL-01 (159 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KE-37 (132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P30-OHK (131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SUP-B15 (167 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LC4-1 (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM1A Tchem Lysine-specific histone demethylase 1 (3916 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOB Tclin Monoamine oxidase B (8835 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 543.69Molecular Weight (Monoisotopic): 543.1662AlogP: 5.23#Rotatable Bonds: 6
Polar Surface Area: 78.95Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.16CX Basic pKa: CX LogP: 5.09CX LogD: 5.09
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.30Np Likeness Score: -1.51

References

1. He X, Zhang H, Zhang Y, Ye Y, Wang S, Bai R, Xie T, Ye XY..  (2022)  Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).,  231  [PMID:35101649] [10.1016/j.ejmech.2022.114143]
2. Song Y, Zhang H, Yang X, Shi Y, Yu B..  (2022)  Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021.,  228  [PMID:34915312] [10.1016/j.ejmech.2021.114042]
3. Dai XJ, Liu Y, Xue LP, Xiong XP, Zhou Y, Zheng YC, Liu HM..  (2021)  Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1.,  64  (5.0): [PMID:33619958] [10.1021/acs.jmedchem.0c02176]

Source